Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Quentin Anstee

Newcastle AuthorsTitleYearFull text
Professor Quentin Anstee
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH2021
Professor Quentin Anstee
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis2021
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Zaki
et al.		Caucasian Lean Subjects with Non-Alcoholic Fatty Liver Disease Share Long-Term Prognosis of Non-Lean: Time for Reappraisal of BMI-Driven Approach?2021
Dr Kate Hallsworth
Dr Stuart McPherson
Professor Quentin Anstee
Laura Haigh
Dr Leah Avery
et al.		Digital Intervention with Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults with Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping2021
Professor Quentin Anstee
Prognostic accuracy of FIB-4, NAFLD fibrosis score, and APRI for NAFLD-related events: a systematic review2021
Professor Quentin Anstee
Priyadarshini Basu
Dr Pallav Bhatnagar
Professor Ann Daly
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis2021
Professor Quentin Anstee
The European ‘NAFLD Preparedness Index’ — is Europe ready to meet the challenge of fatty liver disease?2021
Professor Pierre Bedossa
Professor Quentin Anstee
Professor Arun Sanyal
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study2020
Professor Quentin Anstee
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe2020
Professor Arun Sanyal
Professor Quentin Anstee
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial2020
1234567891011121314151617181920...